Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-25-073234
Filing Date
2025-08-08
Accepted
2025-08-07 19:46:12
Documents
16
Effectiveness Date
2025-08-08

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0252127-s8_nektarthera.htm S-8 37943
2 NEKTAR THERAPEUTICS AMENDED AND RESTATED 2017 PERFORMANCE INCENTIVE PLAN, AS AME ea025212701ex4-8_nektar.htm EX-4.8 126345
3 OPINION OF GOODWIN PROCTER LLP WITH RESPECT TO THE VALIDITY OF THE SECURITIES ea025212701ex5-1_nektar.htm EX-5.1 6953
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea025212701ex23-1_nektar.htm EX-23.1 2240
5 FILING FEE TABLE ea025212701ex-fee_nektar.htm   iXBRL EX-FILING FEES 13688
6 GRAPHIC ex5-1_001.jpg GRAPHIC 4909
  Complete submission text file 0001213900-25-073234.txt   313678

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT ea025212701ex-fee_nektar_htm.xml XML 4801
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289394 | Film No.: 251195848
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)